Coursera
Coursera Logo

PrEParing: PrEP for Providers and Patients 

  • Offered byCoursera

PrEParing: PrEP for Providers and Patients
 at 
Coursera 
Overview

Duration

16 hours

Start from

Start Now

Total fee

Free

Mode of learning

Online

Difficulty level

Beginner

Official Website

Explore Free Course External Link Icon

Credential

Certificate

PrEParing: PrEP for Providers and Patients
 at 
Coursera 
Highlights

  • Shareable Certificate Earn a Certificate upon completion
  • 100% online Start instantly and learn at your own schedule.
  • Flexible deadlines Reset deadlines in accordance to your schedule.
  • Beginner Level
  • Approx. 16 hours to complete
  • English Subtitles: English
Read more
Details Icon

PrEParing: PrEP for Providers and Patients
 at 
Coursera 
Course details

Skills you will learn
More about this course
  • Pre-Exposure Prophylaxis (PrEP) using the antiretroviral medication emtricitibine/tenofovir approved in countries around the world is a highly effective means of reducing transmission of HIV through sexual encounters and needle sharing.
  • This Johns Hopkins University course PrEPares you with essential information, concepts and practical advice regarding PrEP from leaders in the field. A first of its kind learning opportunity, both providers and patients learn from the same experts through content that meets the needs of both audiences, while facilitating the opportunity for a shared community space.
  • Lessons for healthcare workers provide background on foundational and cutting-edge research and PrEP guidelines, how to initiate a PrEP program, clinical management and providing culturally sensitive sexual health and primary care to diverse communities.
  • Lessons for PrEP enthusiasts, PrEP users or the PrEP curious provide information regarding who can benefit from PrEP, how to access services, what to expect and how to stick with your PrEP program long-term.
  • OBJECTIVES:
  • At the conclusion of the session, the participant will be able to:
  • 1. Describe the differences between foundational PrEP studies and demonstration projects
  • 2. Describe the basic pharmacodynamics of tenofovir/emtricitibine including mechanism of infection prevention and time
  • to protective concentration in mucosal tissues
  • 3. List recommendations from PrEP for Prevention of HIV Infection in the United States clinical practice guidelines, USPHS
  • and CDC, including initial and ongoing screening and testing
  • 4. Describe the need for PrEP as an HIV prevention tool for priority in often stigmatized populations
  • 5. Indicate the components for integrating PrEP services into clinical practice
  • 6. Outline guidelines for screening and treatment of sexually transmitted infections
  • 7. Describe how to take a thorough sexual history and to engage with clients around sex in an affirming and non-
  • judgmental manner
  • 8. List the baseline and follow-up laboratory monitoring required
  • 9. Explain key aspects of patient education for HIV prevention and sexual health
  • 10. Describe protocols for ongoing PrEP services and when to discontinue
  • FACULTY/ CREDENTIALS:
  • Jason E. Farley, PhD, MPH, ANP-BC, FAAN, Associate Professor
  • Johns Hopkins University School of Nursing
  • Chris Beyrer, MD, MPH, Professor
  • Johns Hopkins University Bloomberg School of Public Health
  • Yusuf Ariyibi, BA, Disease Intervention Specialist
  • Baltimore City Health Department
  • Joyce Jones, MD, MS, Clinical Associate
  • Johns Hopkins University School of Medicine
  • Neha Sheth Pandit, PharmD, AAHIVP, BCPS, Associate Professor
  • University of Maryland School of Pharmacy
  • Pierre-Cedric Crouch, PhD, ANP-BC, ACRN, Director of Nursing
  • San Francisco AIDS Foundation
  • Renata Arrington Sanders, MD, Assistant Professor
  • Johns Hopkins University School of Medicine
  • Jenell Coleman, MD, MPH, Associate Professor
  • Johns Hopkins University School of Medicine
  • Michele Decker, ScD, MPH, Associate Professor
  • Johns Hopkins University Bloomberg School of Public Health
  • Deborah Dunn, PA-C, MBA, Physician Assistant
  • Chase Brexton Health Care
  • Jordan White, MS, Desmond Tutu Fellow of Public Health and Human Rights
  • Johns Hopkins University Bloomberg School of Public Health
  • Gregory Lucas, MD, PhD, Professor
  • Johns Hopkins University School of Medicine
  • Demetre Daskalakis, MD, MPH, Acting Deputy Commissioner, Division of Disease Control, NYC Dept. of Health and Mental Hygiene
  • David Dowdy, MD, PhD, Associate Professor
  • Johns Hopkins University Bloomberg School of Public Health
  • Jessica LaRicci, PrEP Coordinator
  • Johns Hopkins University School of Nursing
  • Susan Tuddenham, MD, MPH, Assistant Professor
  • Johns Hopkins University School of Medicine
  • Joseph Cofrancesco, MD, MPH, FACP, Associate Professor of Medicine
  • Johns Hopkins University School of Medicine
  • Jill Crank, CRNP, MSN/MPH, Nurse Practitioner
  • Evergreen Healthcare
  • Paul Sacamano, MPH, ANP-BC, ACRN, PrEP Project Lead
  • Johns Hopkins University School of Nursing
  • Shima Ge, BS, PrEP Peer Navigator
  • Johns Hopkins University School of Nursing
  • ORIGINATION DATE October 02, 2017
  • RENEWAL DATE: November 30, 2019
  • EXPIRATION DATE: November 30, 2021
  • URL: https://www.coursera.org/learn/prep/
  • HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser
  • MATERIALS: None
  • TARGET AUDIENCE: physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, health education specialists, public health workers, social workers, case managers
  • PREREQUISITES: None
  • FORMAT: These seminars are enduring video presentations with online discussion forum and resources.
  • CONTACT INFORMATION: Office of The REACH Initiative, Johns Hopkins University School of Nursing (888) 788-7737
  • ACCREDITATION STATEMENTS:
  • CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and Johns Hopkins University School of Nursing. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The Centers for Disease Control and Prevention designates this enduring material for a maximum of 10.75 AMA PRA Category 1 Credits?.
  • CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.1 CEU's for this program.
  • CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 10.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
  • CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • This program is a designated event for pharmacists to receive 1.05 CEUs in pharmacy education. The Universal Activity Number is 0387-9999-19-191-H01-P.
  • Category: This activity has been designated as Knowledge-Based.
  • Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
  • For Certified Public Health Professionals (CPH)
  • The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 11 CPH recertification credits for this program.
  • DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
  • CDC, our planners, our content experts and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Jason Farley and he wishes to disclose that he received grant from Gilead. Planning committee discussed conflict of interest with Dr. Farley to ensure there is no bias.
  • Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Arrington Sander?s discussion of PrEP for adolescents, PrEP is not approved for adolescents < 18 years old; and Dr. Tuddenham?s discussion of STI screening, she will be discussing extra genital screening with NAAT currently recommended by CDC.
  • CDC did not accept commercial support for this continuing education activity.
  • Instructions for Obtaining Continuing Education (CE)
  • In order to receive continuing education (CE) for WD2928- PrEParing: PrEP for Providers and Patients please visit TCEO and follow these 9 Simple Steps before 11/30/2021
  • Complete the activity
  • Complete the Evaluation at https://tceols.cdc.gov/
  • Pass the posttest at 80% at https://tceols.cdc.gov/
  • Email son-reachinititiative@jhu.edu once the above is cpmpleted for CE
  • FEES: No fees are charged for CDC?s CE activities.
Read more

PrEParing: PrEP for Providers and Patients
 at 
Coursera 
Curriculum

Module 1

Course Introduction

Module 1 Introduction

State of the Science

My Decision to Get on PrEP

Demonstration Projects

Is PrEP Right for Me?

Peer Summary

Based on provider-focused and shared content

Module 2

Module 2 Introduction

PrEP and nPEP for HIV Prevention

PrEP: Pharmacodynamics / Pharmacokinetics

Emerging Data/Ongoing Trials for PrEP

Community-Based Implementation of CDC PrEP Guidelines

PrEP Pipeline

Peer Summary

Based on provider-focused and shared content

Module 3

Introduction

PrEP for the Transgender Community

Adolescents & PrEP

Women in Sex Work Exposed to Violence or Coercion

PrEP in Women and Serodifferent Couples

Provider Considerations for Engaging Men Who Have Sex with Men with PrEP

PWID, HIV Infection and PrEP

Adolescents & PrEP

Women in Sex Work Exposed to Violence or Coercion

PrEP in Women and Serodifferent Couples

MSM Self-advocacy and Health Care Empowerment for PrEP

PrEP -- A new tool in the PWID toolkit?

Peer Summary- Module 3

Based on provider-focused and shared content

Module 4

Introduction

Paying for PrEP: Patient Assistance Programs

Should your Clinic Offer PrEP? Build It and They Will Come

PrEP Implementation: A Community Based Nurse-Led Model

Business Case -- Cost-Effectiveness of PrEP

Integrating PrEP into Clinical Practice

PrEP Community Outreach in Baltimore

PrEParing For Pleasure -- Navigating Barriers

Peer Summary

Based on provider-focused and shared content

Module 5

Introduction

The Initial PrEP Visit -- What Providers and Patients Should Know

HIV Prevention -- Sex, Sexual History and PrEP

Sexually Transmitted Infection Screening and PrEP

Laboratory Testing

Patient Education

How to Discuss Sex With Your Provider

How to Take PrEP and the Importance of Adherence

Peer Summary

Based on provider-focused and shared content

Module 6

Introduction

My personal Experience on PrEP

Discontinuing PrEP

Quality of PrEP Programs

Follow-up Labs -- Subsequent Visits

Sexually Transmitted Infections and PrEP -- Focus on Gonorrhea & Chlamydia

PrEP and Genital Ulcer Disease -- Syphilis, Herpes and Human Papilloma Virus

Models of Care & Case Management

Adherence and Retention

Lab Follow-up For Patients

Risk Reduction

Keeping it Real with Your Provider

How to Stay Adherent in the PrEP Program

Peer Summary

Based on provider-focused and shared content

PrEParing: PrEP for Providers and Patients
 at 
Coursera 
Admission Process

    Important Dates

    May 25, 2024
    Course Commencement Date

    Other courses offered by Coursera

    – / –
    3 months
    Beginner
    – / –
    20 hours
    Beginner
    – / –
    2 months
    Beginner
    – / –
    3 months
    Beginner
    View Other 6715 CoursesRight Arrow Icon
    qna

    PrEParing: PrEP for Providers and Patients
     at 
    Coursera 

    Student Forum

    chatAnything you would want to ask experts?
    Write here...